Joint health and treatment modalities in Nordic patients with moderate haemophilia A and B - The MoHem study.
Ragnhild J MåseideErik BerntorpJan AstermarkAnna OlssonMaria BruzeliusTony FriskVuokko NummiRiitta LassilaGeir E TjønnfjordPål A HolmePublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2020)
C ≤ 3 IU/dL and MHA were associated with a more severe bleeding phenotype. We suggest primary prophylaxis to all patients with FVIII/FIX:C ≤ 3 IU/dL.